Qiagen, NL0015002SN0

QIAGEN launches QIAmini as Qiagen stock trades EUR 39.85 versus EUR 39.79

Published on 10/03/2026 at 11:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

QIAGEN launched QIAmini on September 24, 2026. Qiagen stock costs EUR 39.85 in weekend trading on October 3, 2026 versus EUR 39.79 at the October 2 close.

Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht
Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

On September 24, 2026, QIAGEN N.V. announced the launch of QIAmini, a compact automated sample preparation system for research laboratories. In weekend trading at Lang & Schwarz on October 3, 2026, Qiagen stock stood at EUR 39.85 at 11:22 a.m. CEST, versus the EUR 39.79 close at Lang & Schwarz on October 2, 2026. The company announcement is described in the QIAGEN press release.

Qiagen stock in weekend trading

Lang & Schwarz listed the current price at EUR 39.85, compared with the EUR 39.79 close at Lang & Schwarz on October 2, 2026. The quoted change was plus EUR 0.06, equivalent to plus 0.15 percent versus that close. The bid was EUR 39.62 and the ask was EUR 40.09.

The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Qiagen stock.

QIAmini expands sample-preparation automation

According to the QIAGEN release, QIAmini is aimed primarily at academic laboratories and other research customers processing smaller batches. The benchtop system processes up to eight samples per run and automates DNA and RNA extraction and purification. QIAGEN said evaluated workflows showed a reduction in hands-on time of over 80 percent compared with manual sample processing.

The company estimated an addressable market of more than 100,000 potential instrument placements worldwide. QIAmini supports five dedicated kits for DNA and RNA processing from materials including tissue, cells, cheek swabs, whole blood, body fluids and stool. Applications include polymerase chain reaction, digital polymerase chain reaction and next-generation sequencing, the release said.

Next Xetra session

The next Xetra session is scheduled for October 5, 2026. The QIAGEN release identified QIAmini as the company's third new sample preparation system launched in 2026, following QIAsprint Connect and QIAsymphony Connect.

Disclaimer...

en | NL0015002SN0 | QIAGEN | boerse | 70220254 | bgmi